Eikon Therapeutics

Eikon Therapeutics is a new biopharmaceutical company headquartered in Hayward, California. The company employs 303 individuals and reports annual revenue of $100 million. Eikon Therapeutics is dedicated to discovering novel treatments for life-threatening diseases. The company's discovery platform is built around groundbreaking innovations in microscopy, enabling real-time, molecular-resolution measurements of protein movement in living cells. This allows Eikon to directly measure the effects of chemical compounds on protein behavior, identifying compound-protein interactions that traditional assays miss. This uncovers previously inaccessible protein targets for drug development. Eikon's technology generates high-powered, high-content data sets, enabling quantitative exploration of novel biology in living cells. This data-driven approach facilitates the creation of hypotheses and the development of life-saving therapies. For more information about Eikon Therapeutics and potential career opportunities, visit their website at eikontx.com/.